KEGG icon

Drug interaction list


Query:
D10461  Dienogest and estradiol valerate; Natazia (TN)

Interactions: 69 hits    [ ATC classification | Therapeutic category ]

D00211  Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) (P) unclassified
D00229  Amoxicillin (USP); Amoxicillin hydrate (JP18); Amoxicilline (INN); Amoxicillin trihydrate; Amoxil (TN); Dispermox (TN); Pasetocin (TN) (P) unclassified
D00322  Fluconazole (JP18/USP/INN); Diflucan (TN) (P) unclassified
D00435  Nevirapine (JAN/USP/INN); Viramune (TN) (P) unclassified
D00506  Phenobarbital (JP18/USP/INN); Luminal (TN) (P) CYP induction: CYP3A
D00512  Phenytoin (JP18/USP/INN); Dilantin (TN) (P) CYP induction: CYP3A
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) CYP induction: CYP3A
D00850  Minocycline hydrochloride (JP18/USP); Arestin (TN); Dynacin (TN); Minocin (TN); Solodyn (TN) (P) unclassified
D00914  Cefuroxime axetil (JP18/USP/INN); Ceftin (TN) (P) unclassified
D00921  Ceftazidime (USP); Ceftazidime hydrate (JP18); Ceftazidime pentahydrate; Fortaz (TN); Tazicef (TN) (P) unclassified
D01227  Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) (P) unclassified
D01251  Ampicillin hydrate (JP18); Ampicillin trihydrate; Amcill (TN) (P) unclassified
D01668  Sultamicillin tosilate hydrate (JP18); Sultamicillin tosylate dihydrate; Unasyn (TN) (P) unclassified
D02065  Ampicillin sodium and sulbactam sodium (JP18); Unasyn-S (TN) (P) unclassified
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) (P) CYP induction: CYP3A
D02119  Ampicillin sodium (JP18/USP); Omnipen-N (TN); Viccillin (TN) (P) unclassified
D02122  Tetracycline hydrochloride (JP18/USP); Bristacycline (TN) (P) unclassified
D02206  Buformin hydrochloride (JP18); Dibetos-B (TN) (P) unclassified
D02484  Artemether and lumefantrine; Coartem (TN) (P) Enzyme: CYP3A
D02502  Ampicillin and cloxacillin; Viccillin S (TN) (P) unclassified
D02691  Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) (P) unclassified
D03106  Bexarotene (JAN/USAN/INN); Targretin (TN) (P) CYP induction: CYP3A
D03230  Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) (P) unclassified
D03250  Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) (P) unclassified
D04059  Mepenzolate bromide and phenobarbital; Trancolon P (TN) (P) CYP induction: CYP3A
D04121  Exenatide (JAN/USAN/INN); Byetta (TN) (P) unclassified
D04475  Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) (P) unclassified
D04477  Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) (P) unclassified
D04539  Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) (P) unclassified
D04540  Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) (P) unclassified
D04547  Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) (P) unclassified
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) unclassified
D05775  Rufinamide (JAN/USP/INN); Banzel (TN) (P) unclassified
D06485  Amoxicillin hydrate and potassium clavulanate; Augmentin (TN) (P) unclassified
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (P) CYP induction: CYP3A
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (P) unclassified
D08080  Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) (P) unclassified
D09638  Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) (P) unclassified
D09727  Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) (P) unclassified
D09729  Lixisenatide (JAN/USAN/INN); Adlyxin (TN); Lyxumia (TN) (P) unclassified
D09731  Crizotinib (JAN/USAN/INN); Xalkori (TN) (P) CYP inhibition: CYP3A
D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) (P) unclassified
D10372  Palbociclib (JAN/USAN); Ibrance (TN) (P) unclassified
D10519  Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) (P) unclassified
D10520  Rabeprazole, amoxicillin and metronidazole; Rabefine (TN) (P) unclassified
D10551  Ceritinib (JAN/USAN/INN); Zykadia (TN) (P) Enzyme: CYP3A
D10564  Amenamevir (JAN/INN); Amenalief (TN) (P) Enzyme: CYP3A / CYP induction: CYP3A
D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) (P) unclassified
D10643  Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) (P) Enzyme: CYP3A / CYP inhibition: CYP3A
D10762  Fosravuconazole L-lysine ethanolate (JAN) (P) CYP inhibition: CYP3A
D10774  Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) (P) unclassified
D10775  Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) (P) unclassified
D10801  Letermovir (JAN/USAN/INN); Prevymis (TN) (P) CYP inhibition: CYP3A
D10926  Entrectinib (JAN/USAN/INN); Rozlytrek (TN) (P) CYP inhibition: CYP3A
D10990  Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) (P) unclassified
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) Enzyme: CYP3A / CYP induction: CYP3A
D11034  Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) (P) unclassified
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) unclassified
D11138  Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) (P) Enzyme: CYP3A
D11194  Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) (P) unclassified
D11360  Tirzepatide (JAN/USAN); Mounjaro (TN) (P) unclassified
D11370  Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) (P) unclassified
D11485  Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) (P) unclassified
D11567  Insulin degludec and liraglutide; Xultophy (TN) (P) unclassified
D11713  Selpercatinib (JAN/USAN/INN); Retevmo (TN) (P) unclassified
D11920  Pimitespib (JAN); Jeselhy (TN) (P) CYP inhibition: CYP3A
D11970  Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) (P) CYP inhibition: CYP3A
D12055  Sotorasib (JAN/USAN); Lumakras (TN) (P) Enzyme: CYP3A
D12586  Mifepristone and misoprostol; Mefeego (TN) (P) Enzyme: CYP3A / CYP inhibition: CYP3A